David Bredt

Chief Scientific Officer, Rapport Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.1M

Companies

Latest trade

Feb 17, 2026

Companies

Rapport Therapeutics, Inc.Chief Scientific Officer −$1.4M

Trades

RAPP Sold 8,500 shares at $29.02 · planned $0.2M Feb 17

RAPP Sold 8,500 shares at $26.84 · planned $0.2M Jan 15

RAPP Sold 6,567 shares at $30.05 $0.2M Dec 31

RAPP Sold 8,500 shares at $30.02 · planned $0.3M Dec 15

RAPP Sold 8,500 shares at $25.19 · planned $0.2M Nov 17

RAPP Sold 8,500 shares at $25.78 · planned $0.2M Oct 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.